Age- and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004-2011: model-based estimation from two national cross-sectional serosurveys.

L Leon, S Kasereka, F Barin, C Larsen, L Weill-Barillet, X Pascal, Stephane CHEVALIEZ, J Pillonel, M Jauffret-Roustide, Y Le Strat,

Epidemio Infect. 01/04/2017;145(5) : 895-907 10.1017/S0950268816002934. 22/12/2016

IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

C Brisac, S Salloum, V Yang, EA Schaefer, JA Holmes, Stephane CHEVALIEZ, J Hong, C Carlton-Smith, N Alatrakchi, A Kruger, W Lin, RT Chung,

J Hepatol. 01/11/2016;65(5) : 972-979 10.1016/j.jhep.2016.06.028. 09/07/2016

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response.

G Cloherty, Stephane CHEVALIEZ, C Sarrazin, C Herman, V Holzmayer, G Dawson, B Maasoumy, J Vermehren, H Wedemeyer, JJ Feld, Jean-Michel PAWLOTSKY,

Sci Rep. 20/10/2016;6 : 35410 10.1038/srep35410.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

A Ducancelle, A Pivert, S Bertrais, J Boursier, V Balan, P Veillon, H Le Guillou-Guillemette, V Thibault, S Castelain, B Roquebert, M Coste-Burel, V Mackiewicz, E Schvoerer, S Larrat, S Maylin, S Alain, V Loustaud-Ratti, Emmanuel GORDIEN, J Gozlan, V Brodard, Stephane CHEVALIEZ, P Cales, F Lunel-Fabiani,

J Gastroenterol Hepatol. 01/10/2016;31(10) : 1750-1756 10.1111/jgh.13338.

Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 who previously failed a daclatasvir-containing regimen.

Christophe HEZODE, Stephane CHEVALIEZ, G Scoazec, Alexandre SOULIER, A Varaut, Magali BOUVIER-ALIAS, Isaac RUIZ, F Roudot-Thoraval, A Mallat, Cyrille FERAY, Jean-Michel PAWLOTSKY,

Hepatology 01/06/2016;63(6) : 1809-1816 10.1002/hep.28491 10/03/2016

Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.

Stephane CHEVALIEZ, Lila POITEAU, I Rosa, Alexandre SOULIER, F Roudot-Thoraval, S Laperche, Christophe HEZODE, Jean-Michel PAWLOTSKY,

Clin Microbiol Infect. 01/05/2016;22(5) : 459.e1-6 10.1016/j.cmi.2016.01.009. 22/01/2016

Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots.

Lila POITEAU, Alexandre SOULIER, I Rosa, F Roudot-Thoraval, Christophe HEZODE, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

J Viral Hepat. 01/05/2016;23(5) : 399-401 10.1111/jvh.12501 01/02/2016

Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system.

B Seigneres, F Descamps, R Croise, V Barlet, Magali BOUVIER-ALIAS, Stephane CHEVALIEZ, Jean-Michel PAWLOTSKY, W Abdelhady, M Rafik, AM Avellon, JM Echevarria, M Hausmann, JM Dugua,

J Clin Virol. 01/05/2016;78 : 20-26 10.1016/j.jcv.2016.03.001. 04/03/2016

Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen.

Stephane CHEVALIEZ, J Feld, K Cheng, H Wedemeyer, C Sarrazin, B Maasoumy, C Herman, J Hackett, D Cohen, G Dawson, Jean-Michel PAWLOTSKY, G Cloherty,

Antivir Ther. 26/04/2016;- : - 10.3851/IMP3042 24/07/2017

Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring.

Alexandre SOULIER, Lila POITEAU, I Rosa, Christophe HEZODE, F Roudot-Thoraval, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

J Infect Dis. 01/04/2016;213(7) : 1087-1095 10.1093/infdis/jiv423. 02/09/2015